MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
TransMedics Group Market Cap 2011-2026 | TMDX
As of May 11, 2026 TransMedics Group has a market cap of $ 2.31 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap TransMedics Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.69 B | 2.45 B | 2.89 B | 2.22 B | 438 M | 563 M | 281 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.69 B | 281 M | 1.93 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
142 M | $ 3.67 | - | $ 151 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 4.13 | - | $ 155 M |  France |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.81 | - | $ 418 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 7.52 | - | $ 1.13 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.64 | - | $ 67.4 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.22 | - | $ 1.35 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 12.82 | - | $ 363 M | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.65 | - | $ 461 M |  Curacao |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Profound Medical Corp.
PROF
|
166 M | $ 6.85 | - | $ 207 M |  Canada |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.61 | - | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 71.86 | - | $ 3.92 B |  Britain |
 |
Delcath Systems
DCTH
|
326 M | $ 11.48 | - | $ 411 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.35 | - | $ 6.52 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M | Canada |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.83 | - | $ 34.7 M | USA |
 |
Electromed
ELMD
|
175 M | $ 26.93 | - | $ 228 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.16 | - | $ 881 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 285.47 | 0.01 % | $ 109 B | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 154.16 | - | $ 10.8 B | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 77.95 | - | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.76 | - | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 44.26 | - | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 88.12 | - | $ 3.06 B | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 79.96 | - | $ 46.8 B | USA |